The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB1/CB2 receptors

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 10, 2008, Pages 1772-1779

  Baldassarri, S ^a   Bertoni, A ^a   Bagarotti, A ^a   Sarasso, C ^a   Zanfa, M ^a   Catani, M V ^b   Avigliano, L ^b   Maccarrone, M ^c,d   Torti, M ^e   Sinigaglia, Fabiola ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF TERAMO   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

2 Arachidonoylglycerol; Cannabinoid receptors; Platelets; Thromboxane A2

Indexed keywords

ACYLGLYCEROL LIPASE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID 2 ARACHIDONOYLGLYCEROL; FATTY ACID AMIDASE; FURA 2; LIPID; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; THROMBOXANE B2; UNCLASSIFIED DRUG;

ARTICLE; CELL SHAPE; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ARACHIDONIC ACIDS; BLOOD PLATELETS; CALCIUM; CELLS, CULTURED; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; RECEPTORS, CANNABINOID; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

EID: 52449133459     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03093.x     Document Type: Article

References (38)

1. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89-97.
2. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83-90.
3. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932-6.
4. Herkenham M. Localization of cannabinoid receptors in brain and periphery. In: Pertwee RG, ed. Cannabinoid Receptor. London: Academic Press, 1995: 145-66.
5. van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329-32.
6. Brown AJ. Novel cannabinoid receptors. Br J Pharmacol 2007; 152: 567-75.
7. Begg M, Pacher P, Bàtkai S, Osei-Hyiaman D, Offertàler L, Mo FM, Liu J, Kunos G. Evidence for novel cannabinoid receptors. Pharmacol Ther 2005; 106: 133-45.
8. Beltramo M, Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 2000; 11: 1231-5.
9. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Jeorge K. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 1999; 264: 258-67.
10. Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol 2004; 66: 1260-4.
11. Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: Connections with anandamide. Biochem J 1998; 331: 15-9.
12. Sugiura T, Kodaka T, Kondo S, Tonegawa T, Nakane S, Kishimoto S, Yamaschita A, Waku K. Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 1997; 233: 207-10.
13. Matias I, Pochard P, Orlando P, Salzet M, Pestel J, Di Marzo V. Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 2002; 269: 3771-8.
14. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. J Biochem 2004; 135: 517-24.
15. Kishimoto S, Gokoh M, Oka S, Muramatsu M, Kajiwara T, Waku K, Sugiura T. 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB 2 receptor dependent mechanism. J Biol Chem 2003; 278: 24469-75.
16. Maestroni GJ. The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J 2004; 18: 1914-6.
17. Jorda MA, Verbakel SE, Valk PJ, Vankan-Berkhoudt YV, Maccarrone M, Finazzi-Agrò A, Lowenberg B, Delwel R. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 2002; 99: 2786-93.
18. Oka S, Ikeda S, Kishimoto S, Gokoh M, Yanagimoto S, Waku K, Sugiura T. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J Leukoc Biol 2004; 76: 1002-9.
19. Kishimoto S, Muramatsu M, Gokoh M, Oka S, Waku K, Sugiura T. Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J Biochem 2005; 137: 217-23.
20. Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 1998; 243: 838-43.
21. Berdyshev EV, Schmid PC, Krebsbach RJ, Schmid HHO. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J 2001; 15: 2171-8.
22. Maccarrone M, Del Principe D, Finazzi-AgròA. Endocannabinoids: new physiological (co-) agonists of human platelets. Thromb Haemost 2002; 88: 165-6.
23. Maccarrone M, Bari M, Menichelli A, Giuliani E, Del Principe D, Finazzi-AgròA. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem 2001; 268: 819-25.
24. Moro L, Reineri S, Piranda D, Pietrapiana D, Lova P, Bertoni A, Graziani A, Defilippi P, Canobbio I, Torti M, Sinigaglia F. Nongenomic effects of 17β-estradiol in human platelets: Potentiation of thrombin-induced aggregation through estrogen receptor β and Src kinase. Blood 2005; 105: 115-21.
25. Sinigaglia F, Bisio A, Torti M, Balduini CL, Bertolino G, Balduini C. Effect of GpIIb-IIIa complex ligands on calcium ion movement and cytoskeleton organization in activated platelets. Biochem Biophys Res Commun 1988; 154: 258-64.
26. 3H] arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem J 1986; 235: 869-77.
27. 2-induced platelet aggregation. J Biol Chem 1999; 274: 29108-14.
28. Blankman JL, Simon GB, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabiboid 2-arachidonoylglycerol. Chem Biol 2007; 14: 1347-56.
29. Labar G, Bauvois C, Muccioli GG, Wouters J, Lambert DM. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling. Chembiochem 2007; 8: 1293-7.
30. Ghafouri N, Tiger G, Razdan RK, Mahadevan A, Pertwee RG, Martin BR, Fowler CJ. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br J Pharmacol 2004; 143: 774-84.
31. Rock EM, Limebeer CL, Mechoulam R, Piomelli D, Parker LA. The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat. Psychopharmacology 2008; 196: 389-95.
32. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, Murphy V, Pertwee RG, Campbell WB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 1999; 289: 1427-33.
33. Pertwee RG. Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999; 6: 635-64.
34. 2C2 domain for interfacial acitivity. J Biol Chem 2003; 278: 23842-50.
35. Grosser T, Fries S, FitzGerald GA. Thromboxane generation. In: Michelson AD, ed. Platelet. London: Academic Press, 2007: 565-74.
36. Chang MC, Berkery D, Laychock SG, Schuel H. Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana III. Activation of phospholipase A2 in sperm homogenate by delta 9-tetrahydrocannabinol. Biochem Pharmacol 1991; 42: 899-904.
37. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ. The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 1995; 359: 133-6.
38. Kobayashi Y, Arai S, Waku K, Sugiura T. Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J Biochem 2001; 129: 665-9.